Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
09/2003
09/12/2003CA2477449A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477423A1 Aminoalkylphosphonates and related compounds as edg receptor agonists
09/12/2003CA2477125A1 Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity
09/12/2003CA2477119A1 Compounds that modulate the activity of ptp-1b and tc-ptp
09/12/2003CA2476580A1 Thiazole and oxazole derivatives that modulate ppar activity
09/12/2003CA2455447A1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/11/2003WO2003074500A2 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
09/11/2003WO2003074129A1 Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions
09/11/2003US20030171556 Diagnosis and therapeutic treatment of Alzheimer's Disease; drug screening
09/11/2003US20030171547 Adipocyte-specific protein homologs
09/11/2003US20030171541 Selective binding agents, vectors, host cells, and methods for producing GPCR polypeptides; diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with GPCR polypeptides
09/11/2003US20030171429 Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
09/11/2003US20030171422 Aldose reductase inhibitors; antidiabetic agents
09/11/2003US20030171419 Pharmaceutical compositions comprising fluvastatin
09/11/2003US20030171417 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
09/11/2003US20030171411 Amide derivatives as therapeutic agents
09/11/2003US20030171407 Synergistic mixture of insulin secretory stimulant and enzyme inhibitor; hypoglycemic agents, antidiabetic agents
09/11/2003US20030171398 Plant extract; antidiabetic agents
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171389 Anticancer agents; bone disorders; antiarthritic agents
09/11/2003US20030171380 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
09/11/2003US20030171358 New compounds, their preparation and use
09/11/2003US20030171356 Methods for alzheimer's disease treatment and cognitive enhancement
09/11/2003US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
09/11/2003US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24.
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171289 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
09/11/2003US20030171282 Systemic delivery of parathyroid hormone to a mammalian host is accomplished by inhalation through the mouth of a dispersion of an N-terminal fragment of PTH. It has been found that such respiratory delivery of the PTH fragment
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170859 Gene expression inhibition; for treatment of inflammatory, neurological, cardiovascular, and neoplastic tisssue growth disorders
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170643 Regulation of apoB treatment and drug screening for cardiovascular and metabolic disorders or syndromes
09/11/2003US20030170324 Microencapsulated oil
09/11/2003US20030170315 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter
09/11/2003US20030170289 Injectable depot compositions and uses thereof
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170215 Encapsulating a cell culture of propagating pancreatic cells; inserting the encapsulated cells into the mammal permitting the cells to mature to insulin secreting cells
09/11/2003US20030170212 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
09/11/2003US20030170174 For therapy of diseases, such as parasitic and viral infections, conditions associated with inflammation and infection, and conditions mediated by cell-proliferation or collagen formation; contrast agents
09/10/2003EP1342795A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/10/2003EP1342787A2 Arachidonic acid and methods for the production and use thereof
09/10/2003EP1342717A1 Benzimidazole derivatives
09/10/2003EP1342475A1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
09/10/2003EP1342410A2 Transgenic animals lacking a functional galanin gene
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341774A1 Fused heteroaromatic glucokinase activators
09/10/2003EP1341773A2 Substituted 1,3,5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341761A1 SUBSTITUTED INDOLES, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH INDOLES AND THEIR USE AS PPAR-$g(g) BINDING AGENTS
09/10/2003EP1341759A2 3-substituted oxindole beta 3 agonists
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341753A1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1341533A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
09/10/2003EP1341532A2 Use of pyridoxamine for the treatment and inhibition of obesity-related complications
09/10/2003EP1341526A2 Pharmaceutical compositions for the oral delivery of pharmacologically active agents
09/10/2003EP1341497A2 Receptor antagonist-lipid conjugates and delivery vehicles containing same
09/10/2003EP1135389B1 1,4-diazabicyclo 3.2.2]nonane derivatives, their preparation and therapeutic application
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP1085816B1 Dietary supplement derived from fermented milks for the prevention of osteoporosis
09/10/2003EP1023063B1 INDENO[1,2-c], NAPHTHO[1,2-c]- AND BENZO[6,7]CYCLOHEPTA[1,2-c]PYRAZOLE DERIVATIVES
09/10/2003EP0998465B1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
09/10/2003EP0996454B1 Use of polyallylamine polymers for the manufacture of a medicament for treating hypercholesterolemia
09/10/2003EP0914091B1 Ethene containing solutions and use thereof in methods of therapy or prophylaxis
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0896533B1 Pentafluorobenzenesulfonamides and analogs
09/10/2003CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441801A Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
09/10/2003CN1441800A Beta 3 adrenergic agonists
09/10/2003CN1441793A Tocotrienolquinone cyclisation product with anti-hypercholesterol effect
09/10/2003CN1441791A 四唑衍生物 Tetrazole derivative
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441787A Modulators of TNF-alpha signaling
09/10/2003CN1441785A Tetrahydroixoquinoline analogs useful as growth hormone secretagogues
09/10/2003CN1441779A Proline derivatives and use thereof as drugs
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441773A Cyclohexylamine derivative as subtype selective NMDA receptor Antagonists
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441675A Compositions and methods for achieving immune suppression
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/10/2003CN1441666A Macromolecular drug complexes and compositions containing same
09/10/2003CN1440979A Steroid saponin from sealwort as Chinese medicine material and its medicinal use and prepn process
09/10/2003CN1440804A Antilipemic Chinese medicine
09/10/2003CN1440766A Xiaotangning for treating diabetes
09/10/2003CN1440762A Slimming medicine and health food and the prepn process
09/10/2003CN1440758A Bioactive hill wasp powder and its prepn
09/10/2003CN1440753A Children's brain-nourishing chewing gum
09/10/2003CN1440747A Application of chrysophanic acid and chrysophanate in preparing obesity treating medicine
09/10/2003CN1120712C Chinese medicine for reducing cholesterol, biliary calcules and bile viscosity
09/09/2003US6617463 Method for the production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or s2-keto-L-gulonate esters
09/09/2003US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders
09/09/2003US6617426 Peptide analogs of given formula; useful in treating neurodegenerative, autoimmune, cognitive disorders, stroke and traumatic injury
09/09/2003US6617360 Medical treatment
09/09/2003US6617347 Selective β3 adrenergic agonists
09/09/2003US6617344 Heterocyclically substituted benzoylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them
09/09/2003US6617343 Treating non-insulin-dependent diabetes mellitus
09/09/2003US6617327 For therapy of depression and other diseases such as obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders
09/09/2003US6617325 Biphenyl derivatives, production thereof and uses as medicines
1 ... 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 ... 1298